6-morpholino-N-(2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl)pyridine-3-sulfonamide

ID: ALA1079260

PubChem CID: 46882623

Max Phase: Preclinical

Molecular Formula: C19H24N4O3S

Molecular Weight: 388.49

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=S(=O)(Nc1ccc2c(c1)CCNCC2)c1ccc(N2CCOCC2)nc1

Standard InChI:  InChI=1S/C19H24N4O3S/c24-27(25,18-3-4-19(21-14-18)23-9-11-26-12-10-23)22-17-2-1-15-5-7-20-8-6-16(15)13-17/h1-4,13-14,20,22H,5-12H2

Standard InChI Key:  WNSXZWVIMFBNRJ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.7623    3.1475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7610    2.3213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4728    1.9094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4708    3.5597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1091    2.7601    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6861    3.5507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8489    3.6925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7478    1.9629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9052    1.7622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1933    2.3191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1878    3.1515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0474    1.9108    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6652    2.3234    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3788    1.9128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0870    2.9096    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0842    3.0377    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0866    2.3287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7998    1.9189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8014    1.0944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0839    0.6819    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3735    1.0942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5163    0.6825    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2291    1.0964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9402    0.6883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9446   -0.1356    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2315   -0.5497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5143   -0.1398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 12 13  1  0
  1  2  2  0
 13 14  1  0
 11  4  2  0
 13 15  2  0
  4  1  1  0
 13 16  2  0
 14 17  2  0
  5  6  1  0
 17 18  1  0
  6  7  1  0
 18 19  2  0
  5  8  1  0
 19 20  1  0
  9 10  1  0
 20 21  2  0
 21 14  1  0
 22 23  1  0
 10 11  1  0
 11  7  1  0
  8  9  1  0
  2  3  1  0
  2 12  1  0
  3 10  2  0
 22 27  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 19 22  1  0
M  END

Associated Targets(Human)

MLNR Tchem Motilin receptor (1724 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 388.49Molecular Weight (Monoisotopic): 388.1569AlogP: 1.41#Rotatable Bonds: 4
Polar Surface Area: 83.56Molecular Species: BASEHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 7.84CX Basic pKa: 10.00CX LogP: 0.54CX LogD: -0.01
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.82Np Likeness Score: -2.00

References

1. Bailey JM, Scott JS, Basilla JB, Bolton VJ, Boyfield I, Evans DG, Fleury E, Heightman TD, Jarvie EM, Lawless K, Matthews KL, McKay F, Mok H, Muir A, Orlek BS, Sanger GJ, Stemp G, Stevens AJ, Thompson M, Ward J, Vaidya K, Westaway SM..  (2009)  The discovery and optimisation of benzazepine sulfonamide and sulfones as potent agonists of the motilin receptor.,  19  (22): [PMID:19804969] [10.1016/j.bmcl.2009.09.027]

Source